BOTANIX PHARMACEUTICALS LTD

BOT

equity

AUD $0.057

-0.001 (-1.72%)

Updated: 20 Jan, 5:10 am UTC

Description

BOTANIX PHARMACEUTICALS LTD is an ASX-listed company dedicated to the development of novel synthetic cannabidiol (CBD) treatments for a range of skin conditions. It is currently focused on the clinical development of BTX 1503, a novel topical CBD therapy for moderate to severe acne. The company is also exploring other dermatology applications for its CBD platform and is in the process of expanding its clinical development program.

Activity
Last price		$0.057
Change		-0.001 (-1.72%)
Bid/Ask		$0.057 - $0.059
Volume		1.49M
Volume traded/total %		0.13%
Volume avg (4w)		843,248.00
Open		$0.058
Day range		$0.057 - $0.059
Previous Close		$0.058
Last Trade		20 Jan, 5:10 am UTC

Size
Market Cap		$68.87M
Market Rank		1230
Industry Rank		34

Fundamentals
Shares Issued		1.19B
Earnings Per Share (EPS)		$-0.014
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to